Hyperion Therapeutics (HPTX) Jumps: Stock Adds 5.2% - Tale of the Tape


Shutterstock photo

Hyperion Therapeutics, Inc. ( HPTX ) was a big mover last session, as its shares rose over 5% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Nov 29, as the stock is now down over 16%.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate hasn't been in a trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Hyperion currently has a Zacks Rank #3 (Hold) while its  Earnings ESP  is negative.

Some better-ranked medical stocks include Lannett Company, Inc. ( LCI ), Jazz Pharmaceuticals plc ( JAZZ ) and Questcor Pharmaceuticals, Inc. ( QCOR ). All three companies carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 DaysClick to get this free report >>

HYPERION THERAP (HPTX): Free Stock Analysis Report

JAZZ PHARMACEUT (JAZZ): Free Stock Analysis Report

LANNETT INC (LCI): Free Stock Analysis Report

QUESTCOR PHARMA (QCOR): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: HPTX , JAZZ , LCI , QCOR

More from Zacks.com




Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com